These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 27520881)

  • 1. Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.
    Lohr KM; Masoud ST; Salahpour A; Miller GW
    Eur J Neurosci; 2017 Jan; 45(1):20-33. PubMed ID: 27520881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) function in knockout mice affects aging of dopaminergic systems.
    Hall FS; Itokawa K; Schmitt A; Moessner R; Sora I; Lesch KP; Uhl GR
    Neuropharmacology; 2014 Jan; 76 Pt A(0 0):146-55. PubMed ID: 23978383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.
    Masoud ST; Vecchio LM; Bergeron Y; Hossain MM; Nguyen LT; Bermejo MK; Kile B; Sotnikova TD; Siesser WB; Gainetdinov RR; Wightman RM; Caron MG; Richardson JR; Miller GW; Ramsey AJ; Cyr M; Salahpour A
    Neurobiol Dis; 2015 Feb; 74():66-75. PubMed ID: 25447236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice.
    Patel J; Mooslehner KA; Chan PM; Emson PC; Stamford JA
    J Neurochem; 2003 May; 85(4):898-910. PubMed ID: 12716422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture.
    Yamamoto H; Kamegaya E; Hagino Y; Imai K; Fujikawa A; Tamura K; Enokiya T; Yamamoto T; Takeshima T; Koga H; Uhl GR; Ikeda K; Sora I
    Neurochem Int; 2007; 51(2-4):237-44. PubMed ID: 17664021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters.
    Mulvihill KG
    Neurochem Int; 2019 Jan; 122():94-105. PubMed ID: 30465801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.
    Miller GW; Wang YM; Gainetdinov RR; Caron MG
    Methods Mol Med; 2001; 62():179-90. PubMed ID: 21318776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine compartmentalization, selective dopaminergic vulnerabilities in Parkinson's disease and therapeutic opportunities.
    Uhl GR
    Ann Clin Transl Neurol; 2019 Feb; 6(2):406-415. PubMed ID: 30847375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain.
    Purves-Tyson TD; Owens SJ; Rothmond DA; Halliday GM; Double KL; Stevens J; McCrossin T; Shannon Weickert C
    Transl Psychiatry; 2017 Jan; 7(1):e1003. PubMed ID: 28094812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Biogenic Amine Transporters in Trace Amine-Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity.
    Miner NB; Phillips TJ; Janowsky A
    J Pharmacol Exp Ther; 2019 Oct; 371(1):36-44. PubMed ID: 31320495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional deletion of neurexins dysregulates neurotransmission from dopamine neurons.
    Ducrot C; de Carvalho G; Delignat-Lavaud B; Delmas CVL; Halder P; Giguère N; Pacelli C; Mukherjee S; Bourque MJ; Parent M; Chen LY; Trudeau LE
    Elife; 2023 Jul; 12():. PubMed ID: 37409563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron microscopic immunolabeling of transporters and receptors identifies transmitter-specific functional sites envisioned in Cajal's neuron.
    Pickel VM; Garzón M; Mengual E
    Prog Brain Res; 2002; 136():145-55. PubMed ID: 12143378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of dopamine transporter and vesicular monoamine transporter 2 mRNAs in rat midbrain after repeated amphetamine administration.
    Lu W; Wolf ME
    Brain Res Mol Brain Res; 1997 Oct; 49(1-2):137-48. PubMed ID: 9387873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys.
    Stephenson DT; Childs MA; Li Q; Carvajal-Gonzalez S; Opsahl A; Tengowski M; Meglasson MD; Merchant K; Emborg ME
    Cell Transplant; 2007; 16(3):229-44. PubMed ID: 17503735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties.
    Li X; Qi J; Yamaguchi T; Wang HL; Morales M
    Brain Struct Funct; 2013 Sep; 218(5):1159-76. PubMed ID: 22926514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Super-resolution microscopy reveals functional organization of dopamine transporters into cholesterol and neuronal activity-dependent nanodomains.
    Rahbek-Clemmensen T; Lycas MD; Erlendsson S; Eriksen J; Apuschkin M; Vilhardt F; Jørgensen TN; Hansen FH; Gether U
    Nat Commun; 2017 Sep; 8(1):740. PubMed ID: 28963530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular methamphetamine prevents the dopamine-induced enhancement of neuronal firing.
    Saha K; Sambo D; Richardson BD; Lin LM; Butler B; Villarroel L; Khoshbouei H
    J Biol Chem; 2014 Aug; 289(32):22246-57. PubMed ID: 24962577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice.
    Hall FS; Sora I; Uhl GR
    Neuropsychopharmacology; 2003 Apr; 28(4):620-8. PubMed ID: 12655306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorescent-based assay for live cell, spatially resolved assessment of vesicular monoamine transporter 2-mediated neurotransmitter transport.
    Bernstein AI; Stout KA; Miller GW
    J Neurosci Methods; 2012 Aug; 209(2):357-66. PubMed ID: 22698664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A history of ethanol drinking increases locomotor stimulation and blunts enhancement of dendritic dopamine transmission by methamphetamine.
    Tschumi CW; Daszkowski AW; Sharpe AL; Trzeciak M; Beckstead MJ
    Addict Biol; 2020 Jul; 25(4):e12763. PubMed ID: 31062485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.